The use of, and outcomes for, inflammatory bowel disease services during the Covid‐19 pandemic: a nationwide observational study
Alimentary Pharmacology & Therapeutics2022Vol. 55(7), pp. 836–846
Citations Over TimeTop 13% of 2022 papers
Mohammed Deputy, Kapil Sahnan, Guy Worley, Komal Patel, Violeta Balinskaite, Alex Bottle, Paul Aylin, Elaine M. Burns, Ailsa Hart, Omar Faiz
Abstract
There is likely a significant burden of untreated IBD in the community. Patients with IBD may experience clinical harm or protracted decreases in quality of life if care is not prioritised.
Related Papers
- [Inflammatory bowel disease; symptoms and diagnosis of inflammatory bowel diseases].(1988)
- → Origins and Directions of Inflammatory Bowel Disease, Early Studies of the “Nonspecific” Inflammatory Bowel Diseases(2003)6 cited
- → A 5-year study on hospital discharges for pediatric inflammatory bowel diseases in Lombardia(2015)1 cited
- → Inflammatory bowel disease and inflammatory molecules: Chickens, eggs and therapeutic targets(2002)1 cited
- → Mo1835 PREVALENCE OF OCULAR DISEASES IN INFLAMMATORY BOWEL DISEASE (IBD): A NATIONAL, POPULATION-BASED STUDY(2020)